Skip to main content
Clinical Trials/CTRI/2013/03/003495
CTRI/2013/03/003495Completed未知

To compare the clinical effects of beclomethasone dipropionate MDI with spacer and budesonide MDI with spacer in the treatment of children with mild persistent asthma aged 7 to 15 years

A0 sites85 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
A
Enrollment
85

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • patients of newly diagnosed mild persistent asthma (as per GINA GUIDELINES) aged 7 to 15 years were enrolled.Also these patients should show improvement of more than equal to 12% in fev1 after 15 minutes of administration of four separate doses of 100 microgram of salbutamol mdi with spacer. Written informed consent was obtained

Exclusion Criteria

  • The following patients were excluded: Patients who have received oral, parenteral or inhaled steroids during last one month; patients with any underlying chronic illness including cystic fibrosis, pneumothorax, chronic suppurative lung disease, tuberculosis, congenital heart diseases and any other chronic systemic illness; Patients unable to use inhaler with spacer or perform spirometry; patients with lower respiratory tract infections in the last one month; and refusal of consent. Written informed consent was obtained from parents of all subjects.

Investigators

Sponsor
A

Similar Trials